Share
16,584 Posts.
lightbulb Created with Sketch. 681
clock Created with Sketch.
20/11/17
10:18
Share
Originally posted by pevaix
↑
I am back in BDA this week after holding few months ago... IMO the most undervalued play in the medical cannabis space. EV<3mill, growing revenues from their current skincare and supplement range, recently signed a distribution agreement for maternal supplements.
Re MM, Phase I clinical trial designed for their flagship medicinal cannabis product/delivery system and they have already begun formulating a non-pharmaceutical cannabis skincare range for local and international markets (due for release in 2018).
Speculation of-course, but when/if cannabis importation licence is granted I expect the stock to move in a big way. The company's "exclusive relationship with Linnea gives it global access to a standardised GMP-approved cannabis extract ", which is essential for licencing a product in Aus (as in many other markets).
In the meantime, still way undervalued IMO based on the their current growing suite of consumer products and I will continue to add at these levels.
Cheers and GLTA holders!
Expand
Cheapest most advanced pot stock on the market with revenues!
Who the hell would have sold down after the last announcement I don't know but they are crazy!
So cheap it's ridiculous!